Biotech vs. Shorts Message Board

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : Biotech vs. Shorts

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next

To: Vector1 who wrote (6)	7/24/1999 8:24:00 PM
From: Biomaven	Read Replies (2) of 427

V1, professional short players who spread false and misleading rumors and inuendo in an attempt to drive the price of a stock down Bringing these examples to light is exactly what I hope will be done in this thread. Biotechs are uniquely vulnerable to this sort of rumor - by their very nature they have long periods of silence, and it takes a long time before rumors can be disconfirmed. By then the damage is often done. In the case of CLTR we at least had a known short seller (Avon). Perhaps even more troubling are the cases where the only evidence of shorting is unexplained stock declines and a pattern of rumors. Currently GLIA seems to be suffering this fate. Major selling, nasty rumors (Adcon is having problems, etc.), no big published short position, no large number of options outstanding, and no big sales by insiders or large holders that anyone (including the company) has been able to identify. All we are missing is the article in TSC or the New England regional edition of the WSJ, with adverse comments by a short seller "who no longer has a short position." (cough, splutter). Peter

Report TOU Violation

Share This Post

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next